Journal
CLINICAL CASE REPORTS
Volume 10, Issue 2, Pages -Publisher
WILEY
DOI: 10.1002/ccr3.5390
Keywords
adverse effects; ChAdOxl nCoV-19 vaccine; COVID-19 vaccination; Leukocytoclastic Vasculitis due to vaccination; postvacci nation encephalopathy; vaccine-induced thrombotic thrombocytopenia
Categories
Ask authors/readers for more resources
The COVID-19 vaccination programs have sparked debates and concerns over safety issues. This article presents three cases of serious adverse events after receiving the ChAdOx1 nCoV-19 vaccine, emphasizing the importance of investigating and reporting adverse reactions.
In 2020, the SARS-COV-2 disease (COVID-19) imposed huge challenges on the health, economic, and political systems, and by the end of the year, hope had been born with the release of COVID-19 vaccines aimed at bringing the pandemic to an end. However, the COVID-19 vaccination programs have sparked several concerns and ongoing debates over safety issues. Here, we presented three cases of patients with serious adverse events, encephalopathy, vaccine-induced thrombotic thrombocytopenia, and leukocytoclastic vasculitis, after receiving the ChAdOx1 nCoV-19 vaccine. Therefore, it is critical to investigate and report the occurrence of adverse reactions following vaccination, particularly serious ones, as it contributes to the growing body of research and assists clinicians in better diagnosing and managing them.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available